Wedell-Wedellsborg Johan

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$2.75M
Insider Sells Quantity
17
Insider Sells Sum
$28.25M

Insider Activity of Wedell-Wedellsborg Johan

According to the SEC Form 4 filings, Wedell-Wedellsborg Johan, being in a position of

  1. director at Y-mAbs Therapeutics, Inc.,
    оver the last 12 months, has bought 279028 shares for $1.77M, and sold 0 shares,
    over all time since 2019-08-20, has bought 380768 shares for $2.75M, and sold 950000 shares for $28.25M.

The largest purchase of all time was on 2023-05-15 and amounted to 101740 shares of Y-mAbs Therapeutics, Inc. for $981,404.

The largest sale of all time was on 2019-08-20 and amounted to 216256 shares of Y-mAbs Therapeutics, Inc. for $5.93M.

Biography of Wedell-Wedellsborg Johan

No biography is available at this moment.

2023-12-11PurchaseY-mAbs Therapeutics, Inc.
YMAB
director
109,318
0.2637%
$7.00$765,075+103.61%
2023-12-08PurchaseY-mAbs Therapeutics, Inc.
YMAB
director
18,503
0.0418%
$6.99$129,379+90.62%
2023-12-07PurchaseY-mAbs Therapeutics, Inc.
YMAB
director
6,183
0.0135%
$6.50$40,190+98.82%
2023-11-29PurchaseY-mAbs Therapeutics, Inc.
YMAB
director
51,837
0.1191%
$5.97$309,477+123.95%
2023-11-28PurchaseY-mAbs Therapeutics, Inc.
YMAB
director
30,671
0.0702%
$5.81$178,275+130.09%
2023-11-27PurchaseY-mAbs Therapeutics, Inc.
YMAB
director
62,516
0.1416%
$5.49$343,019+140.43%
2023-05-15PurchaseY-mAbs Therapeutics, Inc.
YMAB
director
101,740
0.2186%
$9.65$981,404-31.03%
2021-06-10SaleY-mAbs Therapeutics, Inc.
YMAB
director
11,229
0.0248%
$36.15$405,971-54.57%
2021-06-09SaleY-mAbs Therapeutics, Inc.
YMAB
director
116,700
0.2664%
$36.19$4.22M-53.05%
2021-06-08SaleY-mAbs Therapeutics, Inc.
YMAB
director
33,300
0.0756%
$35.28$1.17M-52.03%
2021-06-07SaleY-mAbs Therapeutics, Inc.
YMAB
director
72,400
0.1618%
$34.15$2.47M-51.15%
2021-06-04SaleY-mAbs Therapeutics, Inc.
YMAB
director
3,841
0.009%
$34.03$130,704-48.25%
2021-06-03SaleY-mAbs Therapeutics, Inc.
YMAB
director
30,666
0.0694%
$33.19$1.02M-48.77%
2021-06-01SaleY-mAbs Therapeutics, Inc.
YMAB
director
6,864
0.016%
$35.57$244,173-50.49%
2021-05-28SaleY-mAbs Therapeutics, Inc.
YMAB
director
25,000
0.0582%
$36.34$908,475-51.42%
2019-09-06SaleY-mAbs Therapeutics, Inc.
YMAB
director
11,582
0.0333%
$27.00$312,714+20.17%
2019-09-05SaleY-mAbs Therapeutics, Inc.
YMAB
director
22,904
0.0676%
$27.00$618,408+23.36%
2019-08-30SaleY-mAbs Therapeutics, Inc.
YMAB
200
0.0006%
$27.00$5,400+22.77%
2019-08-29SaleY-mAbs Therapeutics, Inc.
YMAB
178,132
0.5092%
$26.58$4.73M+20.59%
2019-08-28SaleY-mAbs Therapeutics, Inc.
YMAB
59,104
0.173%
$27.02$1.6M+21.44%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.